Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Adenocarcinoma × irinotecan sucrosofate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 35 Colorectal Neoplasms 16 Small Cell Lung Carcinoma 8 Neoplasms 8 Stomach Neoplasms 7 Biliary Tract Neoplasms 5 Neoplasm Metastasis 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Recurrence 3 Rectal Neoplasms 3 Osteosarcoma 3 Cholangiocarcinoma 3 Triple Negative Breast Neoplasms 2 Solid Tumor 2 Neuroblastoma 2 Nasopharyngeal Carcinoma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Wilms Tumor 1 Weight Loss 1 Somatostatinoma 1 Solid Tumor Cancer 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Refractory Solid Tumors 1

Interventions

Gemcitabine 10 Albumin-Bound Paclitaxel 7 Taxes 5 130-nm albumin-bound paclitaxel 5 Fluorouracil 4 Radiotherapy, Intensity-Modulated 3 Oxaliplatin 3 dehydroftorafur 2 Radiotherapy 2 Leucovorin 2 Irinotecan 2 tocilizumab 1 selicrelumab 1 niraparib 1 irinotecan sucrosofate 1 indusatumab 1 folfirinox 1 durvalumab 1 cobimetinib 1 atezolizumab 1 Tiragolumab 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiosurgery 1 Panitumumab 1 Pancreatectomy 1 PEGPH20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡